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the current treatment provided in real-life situations at 1 
single center and whether these reports consequently led 
to better outcomes. They examined the use of invasive 
evaluation, revascularization rates and both short- and 
long-term outcomes. Although the age-adjusted mortal-
ity rate was similar in women and men, there were still 
significant disparities in treatment. Women with non-
ST-segment elevation myocardial infarction (NSTEMI) 
were less likely to undergo invasive evaluation and PCI 
than their male counterparts.
 There has been much debate on whether women with 
acute coronary syndrome (ACS) should be treated the 
same as men. In ACS, there is no evidence of gender dif-
ferences regarding the benefit of primary PCI for patients 
with ST-segment elevation myocardial infarction (STE-
MI). Halvorsen et al.  [8] show that the gender gap, in 
terms of the likelihood of STEMI patients receiving inva-
sive procedures (coronary angiography and PCI), if ad-
justed for age, does not exist anymore. However, gender 
differences in invasive evaluation and treatment were 
still observed for NSTEMI patients in their Norwegian 
patient cohort. Several trials of unstable angina and 
NSTEMI indicate that women do not benefit from a rou-
tine, early invasive treatment strategy as much as men 
 [9–12] . In the Fifth Organization to Assess Strategies in 
Acute Ischemic Syndromes Investigators (OASIS-5) trial, 
women with NSTEMI did not benefit from a routine in-
 Gender difference in the application of reperfusion 
therapy in patients with acute myocardial infarction 
(AMI) has been an ongoing topic for more than 20 years 
 [1] . Reports have repeatedly shown that women with AMI 
were less likely to undergo reperfusion treatment than 
men, and this persists to the current era  [2–5] . In early 
trials, percutaneous coronary intervention (PCI) was 
also associated with more procedure-related complica-
tions and higher mortality in women than in men  [6, 7] . 
Cardiologists worldwide have since been working on 
closing the gender gap in care. In 2005, the European So-
ciety of Cardiology launched the Women At Heart initia-
tive to raise awareness and improve the quality of care for 
women with cardiovascular disease, and that year, wom-
en and cardiovascular disease were hot topics at the Eu-
ropean Society of Cardiology and American Heart As-
sociation congresses. Numerous sessions and articles 
have been fuelling this gender difference debate, and in 
January 2006,  Circulation devoted an entire section to 
highlighting women’s heart disease. The gender gap has 
meanwhile narrowed, and in more recent studies, report-
ed differences between the genders were less pronounced. 
However, gender differences are still existent as illustrat-
ed in the article from Halvorsen et al.  [8] from the Uni-
versity Hospital in Oslo.
 The authors evaluated whether recent reports on the 
improved outcome for women undergoing PCI affects 
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vasive strategy  [13] . However, another recent publication 
showed that an invasive strategy in NSTEMI patients has 
a comparable benefit in men and in high-risk women, but 
not in low-risk women  [14] .
 Worldwide, women have angina more often than men 
 [15] , and early coronary angiography may be useful for 
risk stratification. However, it is well documented that 
coronary angiography usually shows less extensive ath-
erosclerosis in women. Women who present with ACS 
have a higher incidence of nonobstructive coronary ar-
tery disease. Most trials showed around 20% or greater 
excess of normal or nonobstructive arteries in women 
 [10, 11, 16] . Among ACS patients, the risk-adjusted odds 
ratio of significant coronary artery disease was 0.47 for 
women compared with men  [17] . Halvorsen et al.  [8] con-
firmed this finding in their cohort: a greater percentage 
of women than men with NSTEMI had no obstructive 
coronary artery disease at the time of angiography (23.0 
vs. 8.3%). This could, in part, explain the lesser use of PCI 
in these women, but the benefit of an early invasive strat-
egy for women remains unclear.
 Women admitted for ACS in the University Hospital 
in Oslo were still less likely to receive evidence-based 
medication than men, even after adjustment for age. This 
can be partly explained through the concomitant use of 
platelet inhibitors (aspirin, clopidogrel) and warfarin due 
to atrial fibrillation. The gender gap in treatment should 
not be disturbing but reassuring when based on reliable 
gender-specific data. Increased use of antiplatelet drugs 
has been suggested to play a role for improvements in 
long-term mortality after AMI  [18] . One finding in the 
study of Halvorsen et al.  [8] is of particular interest. No 
gender differences were observed in treatment delay, es-
pecially in the symptom-to-balloon time. Numerous oth-
er studies have reported that women with ACS come lat-
er to hospital which delays the start of therapy. Are Nor-
wegian women more aware of heart disease or is there 
another explanation?
 The findings of this study advance our basic knowl-
edge on gender-specific treatment and suggest that men 
and women now have fairly similar adjusted outcomes 
after PCI. It is important to have such outcome data to 
help us understand the reasons for gender disparities in 
the treatment of AMI.
 We still do not know if and why the gender gap still 
exists or whether it is just a question of age, female condi-
tions and biological differences right down to the cellular 
level. The gender gap in the application of reperfusion 
therapy in patients with AMI narrowed with advancing 
age  [19] . The contemporary American National Registry 
shows women are still less likely to receive reperfusion 
than men. This difference is largest among young pa-
tients, and the gender differences in in-hospital mortality 
are age dependent in both STEMI and NSTEMI patients 
 [20] .
 Crude in-hospital mortality of STEMI and NSTEMI 
patients was higher overall for women than for men. 
However, after adjustment for age and/or comorbidities, 
reported mortality was approximately the same. The re-
sults from Norway raise the question whether long-term 
survival was lower in women, especially in those with 
NSTEMI. The higher mortality rate observed in women 
compared with men after interventional treatment  [21] 
has been explained by differences in body size and clini-
cal risk factors, anatomical differences, basic biological 
differences  [22, 23] and the differing pathophysiology of 
ACS conditions according to age  [24] . However, this ar-
ticle, along with other recent data, suggests that men and 
women now have a fairly similar adjusted outcome after 
PCI  [19] . This outcome improvement in women could be 
due to more invasive evaluation, PCI and stenting as well 
as better procedural management of anticoagulation.
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